HUE037870T2 - Készítmények és módszerek lisztérzékenység kezelésére - Google Patents

Készítmények és módszerek lisztérzékenység kezelésére

Info

Publication number
HUE037870T2
HUE037870T2 HUE12748354A HUE12748354A HUE037870T2 HU E037870 T2 HUE037870 T2 HU E037870T2 HU E12748354 A HUE12748354 A HU E12748354A HU E12748354 A HUE12748354 A HU E12748354A HU E037870 T2 HUE037870 T2 HU E037870T2
Authority
HU
Hungary
Prior art keywords
preparations
methods
celiac disease
treating celiac
treating
Prior art date
Application number
HUE12748354A
Other languages
English (en)
Hungarian (hu)
Inventor
Justin Siegel
David Baker
Sydney Gordon
Ingrid Pultz
Elizabeth Stanley
Sarah Wolf
Original Assignee
Univ Washington Through Its Center For Commercialization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington Through Its Center For Commercialization filed Critical Univ Washington Through Its Center For Commercialization
Publication of HUE037870T2 publication Critical patent/HUE037870T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
HUE12748354A 2011-08-10 2012-08-10 Készítmények és módszerek lisztérzékenység kezelésére HUE037870T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161521899P 2011-08-10 2011-08-10

Publications (1)

Publication Number Publication Date
HUE037870T2 true HUE037870T2 (hu) 2018-09-28

Family

ID=46690751

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE12748354A HUE037870T2 (hu) 2011-08-10 2012-08-10 Készítmények és módszerek lisztérzékenység kezelésére

Country Status (18)

Country Link
US (7) US9289473B2 (show.php)
EP (3) EP3400958B1 (show.php)
JP (5) JP6342802B2 (show.php)
CA (1) CA2882502A1 (show.php)
CY (1) CY1120877T1 (show.php)
DK (1) DK2718434T3 (show.php)
ES (2) ES2896489T3 (show.php)
HR (1) HRP20180687T1 (show.php)
HU (1) HUE037870T2 (show.php)
LT (1) LT2718434T (show.php)
NO (1) NO2718434T3 (show.php)
PL (2) PL3400958T3 (show.php)
PT (1) PT2718434T (show.php)
RS (1) RS57234B1 (show.php)
SI (1) SI2718434T1 (show.php)
SM (1) SMT201800249T1 (show.php)
TR (1) TR201806885T4 (show.php)
WO (1) WO2013023151A2 (show.php)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6342802B2 (ja) 2011-08-10 2018-06-13 ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーションＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｗａｓｈｉｎｇｔｏｎ Ｔｈｒｏｕｇｈ Ｉｔｓ Ｃｅｎｔｅｒ Ｆｏｒ Ｃｏｍｍｅｒｃｉａｌｉｚａｔｉｏｎ セリアックスプルー病を治療するための組成物および方法
EP3033100B1 (en) 2013-08-14 2018-10-03 University Of Washington Through Its Center For Commercialization Compositions for treating celiac sprue disease
EP3081942A1 (en) * 2015-04-17 2016-10-19 Roche Diagniostics GmbH Pressure transmission liquid for cellular analyzer, cellular analyzer and method for analyzing a liquid cellular sample
KR102702879B1 (ko) * 2015-06-08 2024-09-04 유니버시티 오브 워싱턴 셀리악 스프루 질환 치료용 조성물 및 방법
KR102553627B1 (ko) * 2016-12-22 2023-07-07 에베 누트리찌온 게엠베하 안정한 프로테아제 변이체
US20240226248A9 (en) * 2018-10-26 2024-07-11 The Regents Of The University Of California Methods and compositions for improving protein hydrolysis
US20200383351A1 (en) * 2018-10-26 2020-12-10 The Regents Of The University Of California Use of proteolytic enzymes to enhance protein bioavailability
CA3195929A1 (en) 2020-10-30 2022-05-05 Ingrid Swanson Pultz Compositions and methods for treating celiac sprue disease
CA3250056A1 (en) 2022-01-26 2023-08-03 Digestiva, Inc. METHODS AND COMPOSITIONS FOR BLOOD GLUCOSE STABILIZATION
WO2025068987A1 (en) 2023-09-28 2025-04-03 Takeda Pharmaceutical Company Limited A method of producing a kumamolisin-as polypeptide

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688229B1 (fr) 1992-03-09 1995-06-23 Ulice Soc Procede de synthese enzymatique d'esters alkyliques de peptides, produits ainsi obtenus et utilisation desdits produits.
JP2002078489A (ja) * 2000-09-04 2002-03-19 Daiwa Kasei Kk セリン残基が活性発現に関与する新規酸性プロテアーゼ
US7320788B2 (en) * 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
DE60336754D1 (de) 2002-02-14 2011-05-26 Univ R Enzymbehandlung von nahrungsmitteln für zöliakie-sprue
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
US7462688B2 (en) 2002-05-14 2008-12-09 The Board Of Trustees Of The Leland Stanford Junior University Peptides for diagnostic and therapeutic methods for celiac sprue
US7605150B2 (en) 2002-05-14 2009-10-20 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
US7202216B2 (en) 2002-05-14 2007-04-10 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
US7265093B2 (en) 2002-05-14 2007-09-04 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for Celiac Sprue
ES2383595T3 (es) 2002-11-20 2012-06-22 The Board Of Trustees Of The Leland Stanford Junior University Procedimiento de diagnóstico de la celiaquía
US7579313B2 (en) 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
US7563864B2 (en) 2004-04-26 2009-07-21 Celiac Sprue Research Foundation Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten
US7534426B2 (en) 2004-04-26 2009-05-19 The Board Of Trustees Of The Leland Stanford Junior University Glutenase enzyme assays
US7628985B2 (en) 2004-04-26 2009-12-08 The Board Of Regents Of The Leland Stanford Junior University Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
EP1600141B1 (en) 2004-05-24 2013-04-17 3M Deutschland GmbH Collagenolytic active enzyme containing compositions for the treatment of dental caries
EP1726643A1 (en) * 2005-05-27 2006-11-29 Direvo Biotech AG Method for the provision, identification and selection of proteases with altered sensitivity to activity-modulating substances
JP2012500263A (ja) 2008-08-21 2012-01-05 アルヴィン ファーマシューティカルズ インコーポレーティッド タンパク質の経口投与のための製剤
JP6342802B2 (ja) 2011-08-10 2018-06-13 ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーションＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｗａｓｈｉｎｇｔｏｎ Ｔｈｒｏｕｇｈ Ｉｔｓ Ｃｅｎｔｅｒ Ｆｏｒ Ｃｏｍｍｅｒｃｉａｌｉｚａｔｉｏｎ セリアックスプルー病を治療するための組成物および方法
IN2014CN04131A (show.php) 2011-12-06 2015-07-17 Fond Istituto Insubrico Di Ricerca Per La Vita
EP3033100B1 (en) 2013-08-14 2018-10-03 University Of Washington Through Its Center For Commercialization Compositions for treating celiac sprue disease
KR102702879B1 (ko) 2015-06-08 2024-09-04 유니버시티 오브 워싱턴 셀리악 스프루 질환 치료용 조성물 및 방법

Also Published As

Publication number Publication date
JP2021094031A (ja) 2021-06-24
JP6502428B2 (ja) 2019-04-17
US20140178355A1 (en) 2014-06-26
CA2882502A1 (en) 2013-02-14
US9925249B2 (en) 2018-03-27
WO2013023151A3 (en) 2013-07-18
JP6342802B2 (ja) 2018-06-13
US20210085761A1 (en) 2021-03-25
RS57234B1 (sr) 2018-07-31
US9289473B2 (en) 2016-03-22
NO2718434T3 (show.php) 2018-08-25
EP4023243A3 (en) 2022-09-14
SI2718434T1 (en) 2018-06-29
SMT201800249T1 (it) 2018-07-17
ES2896489T3 (es) 2022-02-24
PL2718434T3 (pl) 2018-08-31
JP2024028452A (ja) 2024-03-04
JP2017221201A (ja) 2017-12-21
CY1120877T1 (el) 2019-12-11
US20160166656A1 (en) 2016-06-16
EP3400958B1 (en) 2021-08-04
PL3400958T3 (pl) 2022-01-03
EP4023243A2 (en) 2022-07-06
JP2019162107A (ja) 2019-09-26
US10149892B2 (en) 2018-12-11
US20180185458A1 (en) 2018-07-05
US10874720B2 (en) 2020-12-29
US20190083585A1 (en) 2019-03-21
WO2013023151A2 (en) 2013-02-14
EP3400958A1 (en) 2018-11-14
US12544430B2 (en) 2026-02-10
US20240207376A1 (en) 2024-06-27
EP2718434A2 (en) 2014-04-16
DK2718434T3 (en) 2018-07-09
TR201806885T4 (tr) 2018-06-21
US20170296633A1 (en) 2017-10-19
JP2014529399A (ja) 2014-11-13
US9707280B2 (en) 2017-07-18
HRP20180687T1 (hr) 2018-06-15
ES2667418T3 (es) 2018-05-10
EP2718434B1 (en) 2018-03-28
LT2718434T (lt) 2018-08-10
PT2718434T (pt) 2018-05-21

Similar Documents

Publication Publication Date Title
IL272539B (en) Compositions and methods for immunotherapy
HUS2100021I1 (hu) PCSK9 iRNS készítmények és eljárások azok alkalmazására
IL285985A (en) Therapeutic nuclease compositions and methods
HUS2400023I1 (hu) Készítmények és módszerek anémia kezelésére
HUE051632T2 (hu) Betegségek kezelésére szolgáló készítmények és eljárások
IL269166A (en) Methods and compositions for treating inflammation
HUE037870T2 (hu) Készítmények és módszerek lisztérzékenység kezelésére
HUE053545T2 (hu) Humán immundeficiencia vírus semlegesítõ antitestek és eljárások alkalmazásukra
SMT202000512T1 (it) Anticorpi anti-tau umani
HUE053720T2 (hu) ROR-1 fehérje elleni terápiás antitestek és eljárások alkalmazásukra
HUE045348T2 (hu) Fehérje-hatóanyag konjugátumok és eljárás elõállításukra
BR112014007603A2 (pt) métodos de tratamento do câncer
HUE055505T2 (hu) Anti-CGRP készítmények és alkalmazásuk
BR112013030381A2 (pt) reagentes e métodos para tratar doença dental
EP3131931A4 (en) Methods for increasing red blood cell levels and treating sickle-cell disease
HUE045629T2 (hu) Készítmények, alkalmazások és eljárások anyagcsere rendellenességek és betegségek kezelésére
PT2683384E (pt) Métodos de tratamento de cancro utilizando 3-(5-amino-2-metil-4-oxo-4h-quinazolin-3-il)-piperidina-2,6-diona
HUE046963T2 (hu) Készítmények és kezelés szembetegségekhez és rendellenességekhez
EP2831102A4 (en) NUTRITIONAL FRAGMENTS, PROTEINS THEREFOR AND METHOD
HRP20181457T1 (hr) Anti-htra1 protutijela i postupci uporabe
BR112014031806A2 (pt) método para tratamento de câncer positivo para gd2
HUE036537T2 (hu) ECM kompozíció, tumor-mikrokörnyezet platform és ezekhez eljárások
PT3616695T (pt) Ceftolozano/tazobactam para tratar infeções intrapulmonares
IL227924A0 (en) Compositions and methods of use for determination of he4a
BR112013023142A2 (pt) método de tratamento de cabelos